Ahmed Ghazi, MD
Urology · Rochester, NYNPI 1710280904
Payments from drug & device makers
Across 101 payments — averaging $707.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$12K
- Intuitive Surgical$12K
- Civco Medical Instruments$10K
- Medtronic$9K
- Johnson & Johnson$8K
- Olympus America Inc.$8K
- plus $13K from 14 others
Across 7 payments — averaging $3453.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$24K
What the payments were for
- Consulting fees$19,20027%
- Speaking & faculty fees$30,07042%
- Grants$12,00017%
- Travel & lodging$6,89610%
- Food & beverage$2,7744%
- Education$5551%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 8 | $12,338 |
| Intuitive Surgical | 37 | $12,234 |
| Civco Medical Instruments | 4 | $9,500 |
| Medtronic | 7 | $8,913 |
| Johnson & Johnson | 8 | $8,118 |
| Olympus America Inc. | 9 | $7,796 |
| Ambu Inc. | 3 | $5,571 |
| Ambu A/s | 2 | $4,540 |
| Medical Device Business Services, Inc. | 1 | $1,010 |
| Olympus Corporation | 1 | $540 |
| Astellas Pharma US Inc | 9 | $295 |
| Conmed Corporation | 2 | $244 |
| Richard Wolf Medical Instruments Corp. | 1 | $168 |
| Merck | 2 | $50 |
| Teleflex LLC | 1 | $47 |
| Progenics Pharmaceuticals, Inc. | 2 | $43 |
| Blue Earth Diagnostics | 1 | $29 |
| 180 Medical, Inc. | 1 | $26 |
| Lundbeck LLC | 1 | $18 |
| Telix Pharmaceuticals | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$11,531
- Monarch Platform$7,866
- GENERAL - THERAPIES$5,141
- GENERAL ERECTILE DYSFUNCTION$2,000
- CONMED SPECIMEN RETRIEVAL$244
- AIRSEAL$244
- Soltive$146
- Moses 550 DFL$134
- XTANDI$112
- GIA$103
How this compares
$71,495 in reported general payments places this provider in the 90th percentile of 952 urology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 18 | $241 |
Paid to pharmacies, not to this prescriber.
Other urology in Rochester
- Christopher PieczonkaSyracuse$31.2M
- Guarionex DecastroNew York$5.7M
- Mitchell EfrosGarden City$4.2M
- James McKiernanNew York$4.1M
- William HuangNew York$3.9M
- Jed KaminetskyMiddle Village$3.5M
- Evan GoldfischerPoughkeepsie$3.1M
- Gennady BratslavskySyracuse$2.5M
- Ashutosh TewariNew York$2.5M
- Manish ViraNew Hyde Park$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.